Is It Time To Reassess Elevance Health (ELV) After Its Recent Share Price Weakness

Simply Wall St.01-10

If you are wondering whether Elevance Health shares offer good value right now, the story starts with how the current price lines up against a few different valuation checks. The stock last closed at ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602587553?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","is_english":true,"pubTime":"2026-01-10 18:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602587553","market":"nz","top_or_hot":-1,"title":"Is It Time To Reassess Elevance Health (ELV) After Its Recent Share Price Weakness","media":"Simply Wall St.","content":"<div>\n<p>If you are wondering whether Elevance Health shares offer good value right now, the story starts with how the current price lines up against a few different valuation checks. The stock last closed at ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-its-recent\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time To Reassess Elevance Health (ELV) After Its Recent Share Price Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time To Reassess Elevance Health (ELV) After Its Recent Share Price Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-10 18:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-its-recent><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are wondering whether Elevance Health shares offer good value right now, the story starts with how the current price lines up against a few different valuation checks. The stock last closed at ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-its-recent\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0187121727.USD","symbol_name":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-its-recent","article_id":"2602587553","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-its-recent","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2602587553","pubTimestamp":1768040565,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are wondering whether Elevance Health shares offer good value right now, the story starts with how the current price lines up against a few different valuation checks.\nThe stock last closed at US$372.83, with returns of 5.2% over the past week, 9.3% over the past month, 5.2% year to date, a 0.3% decline over the past year, a 19.2% decline over three years, and 22.2% over five years, which gives investors a mixed set of signals about recent momentum and longer term performance.\nRecent...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","LU0985489474.SGD":"First Eagle Amundi International AHS-C SGD-H","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","BK7095":"多种金属与采矿","LU0251142724.SGD":"Fidelity America A-SGD","ELV.AU":"ELEVRA LITHIUM LTD","SG9999001077.SGD":"United International Growth Fund SGD","LU0878866978.SGD":"First Eagle Amundi International AHS-QD SGD-H","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","LU0433182093.SGD":"First Eagle Amundi International AS-C SGD","LU0557290698.USD":"施罗德环球可持续增长基金","LU0061474960.USD":"天利环球焦点基金AU Acc","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","BK4154":"管理型保健护理","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU1548497426.USD":"安联环球人工智能AT Acc","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","ELV":"Elevance Health","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD"},"translate_title":"Elevance Health(ELV)近期股价疲软后，是时候重新评估其股价了吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1.5,"ELV.AU":1.5,"DCF":1},"content_text":"If you are wondering whether Elevance Health shares offer good value right now, the story starts with how the current price lines up against a few different valuation checks. The stock last closed at US$372.83, with returns of 5.2% over the past week, 9.3% over the past month, 5.2% year to date, a 0.3% decline over the past year, a 19.2% decline over three years, and 22.2% over five years, which gives investors a mixed set of signals about recent momentum and longer term performance. Recent coverage of Elevance Health has focused on its position in the US healthcare and insurance space, as investors weigh how the current share price reflects expectations for the business. This context is important when you look at those return figures, because sentiment around large health insurers can shift as investors reassess risk and growth potential. On our valuation checks, Elevance Health scores 5 out of 6 for being undervalued. You can see the full breakdown in the valuation score of 5/6. We will unpack this using several approaches before coming back to an even more useful way to think about value at the end of this article.  Elevance Health delivered -0.3% returns over the last year. See how this stacks up to the rest of the Healthcare industry. AdvertisementApproach 1: Elevance Health Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow, or DCF, model estimates what a company could be worth today by projecting its future cash flows and then discounting those back into present dollars. It is essentially asking what all those future cash flows are worth to you right now. For Elevance Health, the latest twelve month Free Cash Flow is about $3.6b. Using a 2 Stage Free Cash Flow to Equity model, analysts and extrapolations feed in a series of forecasts, with projected Free Cash Flow of $8.98b by 2030. Analysts provide inputs for the earlier years and, after that, Simply Wall St extends the series using its own growth assumptions. When all of those projected cash flows are discounted back into today’s money, the model arrives at an estimated intrinsic value of about $1,011.50 per share. Set against the recent share price of $372.83, this implies a discount of roughly 63.1%. On this DCF view the shares screen as materially undervalued. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Elevance Health is undervalued by 63.1%. Track this in your watchlist or portfolio, or discover 879 more undervalued stocks based on cash flows. ELV Discounted Cash Flow as at Jan 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Elevance Health. Approach 2: Elevance Health Price vs Earnings For a profitable company like Elevance Health, the P/E ratio is a useful yardstick because it links what you pay per share to the earnings the business is already generating. Investors generally accept paying a higher P/E when they see stronger earnings growth potential and lower perceived risk, while slower growth or higher uncertainty usually supports a lower, more conservative P/E. Elevance Health currently trades on a P/E of about 15x. That sits below the wider Healthcare industry average of about 22.9x and also below the peer group average of roughly 24x. Simply Wall St’s Fair Ratio for Elevance Health is 33.18x, which is its view of what a reasonable P/E might be after weighing factors like earnings growth expectations, profit margins, industry, market cap and specific risks. This Fair Ratio is designed to be more tailored than a simple comparison with industry or peers, because it adjusts for the company’s own characteristics rather than assuming all insurers or healthcare names deserve the same multiple. Set against the current P/E of about 15x, the Fair Ratio of 33.18x suggests the shares screen as undervalued on this metric. Result: UNDERVALUED NYSE:ELV P/E Ratio as at Jan 2026 P/E ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1444 companies where insiders are betting big on explosive growth. Upgrade Your Decision Making: Choose your Elevance Health Narrative Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives. These are simply your story about Elevance Health, linked to your assumptions for future revenue, earnings and margins. Those assumptions then flow through to a financial forecast, an estimated fair value and a clear comparison against today’s share price on the Simply Wall St Community page used by millions of investors. Do you think there's more to the story for Elevance Health? Head over to our Community to see what others are saying! NYSE:ELV 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Elevance Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602587553","isCrawlerRequest":true}